Takashi Fukuda

Corporate Officer/Principal en SANKYO CO., LTD. .

Producer Manufacturing

Health Technology

Perfil

Takashi Fukuda has held the following positions in his career: Director & Senior Managing Director at ARK Resource Co. Ltd.
and Executive Officer & Deputy GM-Products at Sankyo Co., Ltd.

Cargos activos de Takashi Fukuda

Empresas	Cargo	Inicio
SANKYO CO., LTD.	Corporate Officer/Principal	29/10/2010
ARK Resource Co. Ltd. ARK Resource Co. Ltd. BiotechnologyHealth Technology ARK Resource Co. Ltd. is a Japanese company that specializes in the manufacturing of monoclonal and polyclonal antibodies, fertilized eggs in mouse/rats, and culture used for reproductive engineering. ARK Resource Co. was founded in 1966 and is based in Kumamoto, Japan, with headquarters located at 383-2 Nakahara-cho, Nishi-ku, Kumamoto-shi, Kumamoto. The company offers a wide range of services from units to g units, including the supply of mouse monoclonal antibodies by ascelonus method and culture method. The company also provides a quick diagnostic genetic modified animal breeding colony by the service introduction pcr method, performing homo / hetero / wild type screening (geno typing). The company can identify specific disease bacteria in biological samples and culture cells.	Director/Board Member	-

Todos los cargos activos de Takashi Fukuda

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Takashi Fukuda.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SANKYO CO., LTD.	Producer Manufacturing

Empresas privadas	1
ARK Resource Co. Ltd. ARK Resource Co. Ltd. BiotechnologyHealth Technology ARK Resource Co. Ltd. is a Japanese company that specializes in the manufacturing of monoclonal and polyclonal antibodies, fertilized eggs in mouse/rats, and culture used for reproductive engineering. ARK Resource Co. was founded in 1966 and is based in Kumamoto, Japan, with headquarters located at 383-2 Nakahara-cho, Nishi-ku, Kumamoto-shi, Kumamoto. The company offers a wide range of services from units to g units, including the supply of mouse monoclonal antibodies by ascelonus method and culture method. The company also provides a quick diagnostic genetic modified animal breeding colony by the service introduction pcr method, performing homo / hetero / wild type screening (geno typing). The company can identify specific disease bacteria in biological samples and culture cells.	Health Technology